AKT1 mutations have been reported in 1.4% to 8% (average ~4%) invasive ductal breast carcinoma [15–18], and the oncogenic mutant loci E17K in AKT1 has been considered as a potential diagnosis biomarker of breast cancer [19]. Here, AKT1 is linked to breast carcinoma.